Publications by authors named "Manal Abdelmalek"

Claim this Profile

Mentions over time

Mentions by platform

Video Views

72,495

Total Likes

1,322

Extended Reach

77,159

Social Features

3
C
Comparison of free fructose and glucose to sucrose in the ability to cause fatty liver.
Laura G Sánchez-Lozada, Wei Mu, Carlos Roncal, Yuri Y Sautin, Manal Abdelmalek, Sirirat Reungjui, MyPhuong Le, Takahiko Nakagawa, Hui Y Lan, Xuequing Yu

February 2010

Videos about Article: user user

2 2 1 2

View All Article and Social Media Activity
B
Biomarkers of Histological Response in Lanifibranor-treated Patients With Metabolic Dysfunction-associated Steatohepatitis.
Jérôme Boursier, Hugo Hervé, Marine Roux, Manal F Abdelmalek, Sven M Francque

Clin Gastroenterol Hepatol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Elevated Homocysteine is Associated With Liver Fibrosis in Metabolic Dysfunction-Associated Steatotic Liver Disease in a Sex- and Menopause-Specific Manner.
Mizuki Suzuki, Hwi Young Kim, Michael C Reed, H Frederik Nijhout, Allison Cruikshank, Manal Abdelmalek

Gastro Hep Adv· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Age-specific protective effects of statins against cirrhosis in patients with chronic liver enzyme elevation associated with metabolic dysfunction: a retrospective cohort study of electronic health records.
Ayako Suzuki, Georgia Sofia Karachaliou, Amy M Perkins, Chad Dorn, Ruth M Reeves, Manal F Abdelmalek

EClinicalMedicine· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Peppermint oil-associated hepatotoxicity.
Kinsie Ali, Gad Mehanna Al Snih, Arthur Beyder, Manal F Abdelmalek

J Hepatol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Liver in Diabetes and Metabolic Syndrome.
Mia C Mahmoud, Manal F Abdelmalek

Clin Liver Dis· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Betaine in the treatment of steatotic liver disease-Historical fad or a timeless treasure worth reviving?
Manal F Abdelmalek, Keith D Lindor

Hepatology· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) in People With Diabetes: The Need for Screening and Early Intervention. A Consensus Report of the American Diabetes Association.
Kenneth Cusi, Manal F Abdelmalek, Caroline M Apovian, Kirthikaa Balapattabi, Raveendhara R Bannuru

Diabetes Care· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Altered liver sinusoidal endothelial cells in MASLD and their evolution following lanifibranor treatment.
Pierre-Emmanuel Rautou, Shivani Chotkoe, Louise Biquard, Guillaume Wettstein, Denise van der Graaff, Manal F Abdelmalek

JHEP Rep· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ACG Clinical Guideline: Malnutrition and Nutritional Recommendations in Liver Disease.
Ashwani K Singal, Robert J Wong, Srinivasan Dasarathy, Manal F Abdelmalek, Brent A Neuschwander-Tetri

Am J Gastroenterol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Author Correction: Targeting senescent hepatocytes for treatment of metabolic dysfunction-associated steatotic liver disease and multi-organ dysfunction.
Kuo Du, David S Umbaugh, Liuyang Wang, Ji Hye Jun, Rajesh K Dutta, Manal F Abdelmalek

Nat Commun· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incident heart failure is common and underrecognized in patients with biopsy-proven metabolic dysfunction-associated steatotic liver disease.
Kara Wegermann, Fouad Chouairi, Georgia Sofia Karachaliou, Carolyn Ahlers, Sandra Au, Manal F Abdelmalek

Eur J Heart Fail· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Osteopontin Promotes Cholangiocyte Secretion of Chemokines to Support Macrophage Recruitment and Fibrosis in MASH.
Jason D Coombes, Paul P Manka, Marzena Swiderska-Syn, Danielle T Vannan, Antonio Riva, Manal F Abdelmalek

Liver Int· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Renin-angiotensin-aldosterone system inhibitor use improves clinical outcomes in patients with metabolic dysfunction-associated steatotic liver diseases: Target trial emulation using real-world data.
Wee Han Ng, Yee Hui Yeo, Hyunseok Kim, Ekihiro Seki, Jonathan Rees, Manal Abdelmalek

Hepatology· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Current and emerging strategies for the prevention of hepatocellular carcinoma.
Yee Hui Yeo, Manal Abdelmalek, Seema Khan, Cynthia A Moylan, Luz Rodriquez

Nat Rev Gastroenterol Hepatol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ALADDIN: A Machine Learning Approach to Enhance the Prediction of Significant Fibrosis or Higher in Metabolic Dysfunction-Associated Steatotic Liver Disease.
Naim Alkhouri, Terry Cheuk-Fung Yip, Laurent Castera, Marina Takawy, Leon A Adams, Manal F Abdelmalek

Am J Gastroenterol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting senescent hepatocytes for treatment of metabolic dysfunction-associated steatotic liver disease and multi-organ dysfunction.
Kuo Du, David S Umbaugh, Liuyang Wang, Ji Hye Jun, Rajesh K Dutta, Manal F Abdelmalek

Nat Commun· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Weight Loss on Metabolic Dysfunction Associated Steatohepatitis and Hepatic Fibrosis.
Marina W Takawy, Manal F Abdelmalek

Curr Diab Rep· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An Infiltrative Case of Angiosarcoma Causing Portal Hypertension.
Gina Bae, Katie A Dunleavy, Catherine Hagen, Douglas A Simonetto, Manal F Abdelmalek

ACG Case Rep J· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hepatologist Consultation in Low-Risk MASLD.
Abigail Schubach, Rotonya M Carr, Manal F Abdelmalek

N Engl J Med· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Steatotic liver disease, a useful construct in primary care that doesn't upset the apple cart.
Manal F Abdelmalek, Mary E Rinella

Hepatology· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The role of glucagon-like peptide-1 receptor agonists in metabolic dysfunction-associated steatohepatitis.
Manal F Abdelmalek, Stephen A Harrison, Arun J Sanyal

Diabetes Obes Metab· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The pan-PPAR agonist lanifibranor improves cardiometabolic health in patients with metabolic dysfunction-associated steatohepatitis.
Michael P Cooreman, Javed Butler, Robert P Giugliano, Faiez Zannad, Lucile Dzen, Manal F Abdelmalek

Nat Commun· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Alterations in zonal distribution and plasma membrane localization of hepatocyte bile acid transporters in patients with NAFLD.
William A Murphy, Anna Mae Diehl, Matthew Shane Loop, Dong Fu, Cynthia D Guy, Manal F Abdelmalek

Hepatol Commun· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 2, open-label, rollover study of cenicriviroc for liver fibrosis associated with metabolic dysfunction-associated steatohepatitis.
Sven M Francque, Alexander Hodge, Jerome Boursier, Ziad H Younes, Gerardo Rodriguez-Araujo, Manal F Abdelmalek

Hepatol Commun· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis